Select Equity Group, L.P. Bio Techne Corp Transaction History

Select Equity Group, L.P.

$20.4 Billion
Q3 2025

A detailed history of Select Equity Group, L.P. transactions in Bio Techne Corp stock. As of the latest transaction made, Select Equity Group, L.P. holds 2,251,593 shares of TECH stock, worth $134 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares

2,251,593

Previous 2,919,495 22.88%

Holding current value

$134 Million

Previous $150 Million 16.61%

% of portfolio

0.62%

Previous 0.74%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$49.87 - $58.78 $33.3 Million - $39.3 Million	-667,902 Reduced 22.88%	2,251,593 $125 Million
Q2 2025 Aug 14, 2025	SELL	$46.66 - $58.38 $114 Million - $143 Million	-2,446,508 Reduced 45.59%	2,919,495 $150 Million
Q1 2025 May 15, 2025	BUY	$58.47 - $78.75 $177 Million - $239 Million	3,030,644 Added 129.77%	5,366,003 $315 Million
Q4 2024 Feb 14, 2025	BUY	$66.37 - $78.17 $32.9 Million - $38.7 Million	495,404 Added 26.92%	2,335,359 $168 Million
Q3 2024 Nov 14, 2024	SELL	$70.96 - $82.35 $48 Million - $55.7 Million	-676,078 Reduced 26.87%	1,839,955 $147 Million

Q2 2024 Aug 14, 2024	SELL	$62.12 - $84.15 $30.7 Million - $41.6 Million	-494,710 Reduced 16.43%	2,516,033 $180 Million
Q1 2024 May 15, 2024	SELL	$65.98 - $77.09 $102 Million - $119 Million	-1,548,430 Reduced 33.96%	3,010,743 $212 Million
Q4 2023 Feb 14, 2024	BUY	$52.83 - $78.22 $2.38 Million - $3.53 Million	45,095 Added 1.0%	4,559,173 $352 Million
Q2 2023 Aug 14, 2023	SELL	$73.76 - $85.98 $83.1 Million - $96.9 Million	-1,126,819 Reduced 19.98%	4,514,078 $368 Million
Q1 2023 May 15, 2023	SELL	$71.62 - $86.62 $108 Million - $131 Million	-1,513,050 Reduced 21.15%	5,640,897 $418 Million
Q4 2022 Feb 14, 2023	BUY	$80.67 - $352.29 $458 Million - $2 Billion	5,672,587 Added 382.93%	7,153,947 $593 Million
Q3 2022 Nov 14, 2022	BUY	$282.54 - $391.85 $45.2 Million - $62.7 Million	159,929 Added 12.1%	1,481,360 $421 Million
Q2 2022 Aug 15, 2022	BUY	$322.67 - $449.65 $201 Million - $280 Million	622,945 Added 89.19%	1,321,431 $458 Million
Q1 2022 May 16, 2022	BUY	$353.85 - $487.79 $247 Million - $341 Million	698,486 New	698,486 $302 Million
Q2 2021 Aug 16, 2021	SELL	$387.35 - $450.26 $72.2 Million - $83.9 Million	-186,301 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$314.62 - $411.0 $8.57 Million - $11.2 Million	-27,240 Reduced 12.76%	186,301 $71.2 Million
Q4 2020 Feb 16, 2021	BUY	$246.9 - $321.87 $52.7 Million - $68.7 Million	213,541 New	213,541 $67.8 Million
Q3 2020 Nov 16, 2020	SELL	$232.22 - $282.96 $3.1 Million - $3.78 Million	-13,357 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$185.43 - $279.56 $59.1 Million - $89.1 Million	-318,818 Reduced 95.98%	13,357 $3.53 Million
Q1 2020 May 15, 2020	BUY	$161.17 - $221.51 $53.5 Million - $73.6 Million	332,175 New	332,175 $63 Million
Q1 2019 May 15, 2019	SELL	$136.09 - $200.44 $24.5 Million - $36.1 Million	-180,123 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$132.75 - $203.8 $23.9 Million - $36.7 Million	180,123 New	180,123 $26.1 Million
Q3 2018 Nov 14, 2018	SELL	$147.44 - $204.11 $39.7 Million - $55 Million	-269,309 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$144.9 - $165.58 $56.3 Million - $64.3 Million	-388,570 Reduced 59.06%	269,309 $0
Q1 2018 May 15, 2018	SELL	$131.46 - $151.04 $89.6 Million - $103 Million	-681,881 Reduced 50.9%	657,879 $0
Q4 2017 Feb 14, 2018	SELL	$121.17 - $134.75 $44.9 Million - $49.9 Million	-370,154 Reduced 21.65%	1,339,760 $0
Q3 2017 Nov 14, 2017	BUY	$113.59 - $123.78 $194 Million - $212 Million	1,709,914	1,709,914 $0

Others Institutions Holding TECH

# of Institutions

648

Shares Held

162M

Call Options Held

514K

Put Options Held

347K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.33B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Select Equity Group, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Select Equity Group, L.P. with notifications on news.

Account

Select Equity Group, L.P. Bio Techne Corp Transaction History